Search

Your search keyword '"Monda, Kl"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Monda, Kl" Remove constraint Author: "Monda, Kl"
128 results on '"Monda, Kl"'

Search Results

1. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry

2. How well can familial hypercholesterolemia be identified in an electronic health record database?

3. Quality control and conduct of genome-wide association meta-analyses

4. Defining the role of common variation in the genomic and biological architecture of adult human height

5. Development of algorithms for identifying fatal cardiovascular disease in Medicare claims

6. Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States

7. Biological interpretation of genome-wide association studies using predicted gene functions

8. Genome-wide physical activity interactions in adiposity. A meta-analysis of 200,452 adults

9. A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape

10. Biological interpretation of genome-wide association studies using predicted gene functions

11. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study

12. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

13. Sex-stratified Genome-wide Association Studies Including 270,000 Individuals Show Sexual Dimorphism in Genetic Loci for Anthropometric Traits

14. Erratum: Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height ((The American Journal of Human Genetics (2010) 88 (6-18))

15. Erratum: Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution (Nature Genetics (2010) 42 (949-960))

16. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

17. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

18. Hundreds of variants clustered in genomic loci and biological pathways affect human height

19. Genome-Wide Association of Body Fat Distribution in African Ancestry Populations Suggests New Loci

20. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

21. Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children

22. NRXN3 Is a Novel Locus for Waist Circumference: A Genome-Wide Association Study from the CHARGE Consortium

24. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

25. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

26. Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data.

27. Retrospective comparison of traditional and artificial intelligence-based heart failure phenotyping in a US health system to enable real-world evidence.

28. Ancestral diversity in lipoprotein(a) studies helps address evidence gaps.

29. Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

30. Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease.

31. Long-Term Levels of LDL-C and Cognitive Function: The CARDIA Study.

32. Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction.

33. Death, long-term nursing home placement, and impoverishment after recurrent myocardial infarction.

34. Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans.

35. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.

36. Atherosclerotic Risk and Statin Use Among Patients With Peripheral Artery Disease.

37. Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation.

38. Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction.

39. Trends in statin utilization among adults with severe peripheral artery disease including critical limb ischemia in an integrated healthcare delivery system.

40. Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era.

41. PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults.

42. Real world evidence in cardiovascular medicine: ensuring data validity in electronic health record-based studies.

43. Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease.

44. Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male.

45. Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries.

46. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.

47. Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.

48. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

49. Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999-2014.

50. Adherence to Statin Therapy Among US Adults Between 2007 and 2014.

Catalog

Books, media, physical & digital resources